| Bioactivity | Hydroxyprogesterone caproate is a synthetic, steroidal progestin; an ester derivative of 17α-hydroxyprogesterone formed from caproic acid. | ||||||||||||
| Name | Hydroxyprogesterone caproate | ||||||||||||
| CAS | 630-56-8 | ||||||||||||
| Formula | C27H40O4 | ||||||||||||
| Molar Mass | 428.60 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Armstrong J. Unintended consequences--the cost of preventing preterm births after FDA approval of a branded version of 17OHP. N Engl J Med. 2011 May 5;364(18):1689-91. [2]. Hauth JC, et al. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Am J Obstet Gynecol. 1983 May 15;146(2):187-90. |